Close

CVS Health (CVS) Announces Expansion of Naloxone Accessibility

Go back to CVS Health (CVS) Announces Expansion of Naloxone Accessibility

CVS Health Expands Access to Opioid Overdose-Reversal Drug for CVS Pharmacy Patients in Five Additional States

September 29, 2016 8:31 AM EDT

WOONSOCKET, R.I., Sept. 29, 2016 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced it has expanded access to the opioid overdose-reversal drug naloxone in Alabama, Alaska, Illinois, Missouri and West Virginia, allowing CVS Pharmacy patients to access the medication without an individual prescription.  In total, CVS Pharmacy patients in 36 states now have increased access to the life-saving opioid overdose-reversal drug.  CVS Health's naloxone program establishes a standing order with a physician in the state or utilizes pharmacists' prescriptive authority to permit CVS Pharmacists to dispense naloxone to patients without an individual prescription. ... More